THERMO FISHER SCIENTIFIC INC. TMO

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $588.00
Market Cap $221.37B
P/E Ratio 33.15
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑3.9% YoY
$44.56B
3-Yr CAGR: -0.3%
Net Income ↑5.8% YoY
$6.70B
Net Margin: 15.0%
Free Cash Flow ↓-13.4% YoY
$6.29B
FCF Yield: 2.84%
EPS (Diluted) ↑7.3% YoY
$17.74
Basic: $17.77
Return on Equity Efficiency
12.6%
ROA: 6.1%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (TMO)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $18,274.1M $10,060.2M $2,021.8M $5.09 $3,257.8M $2,813.4M
FY 2017 $20,918.0M +14.5% $11,942.0M $2,225.0M +10.1% $5.59 +9.8% $4,005.0M $3,497.0M +24.3%
FY 2018 $24,358.0M +16.4% $10,857.0M $2,938.0M +32.0% $7.24 +29.5% $4,543.0M $3,785.0M +8.2%
FY 2019 $25,542.0M +4.9% $11,328.0M $3,696.0M +25.8% $9.17 +26.7% $4,973.0M $4,047.0M +6.9%
FY 2020 $32,218.0M +26.1% $16,004.0M $6,375.0M +72.5% $15.96 +74.0% $8,289.0M $6,815.0M +68.4%
FY 2021 $39,211.0M +21.7% $19,638.0M $7,725.0M +21.2% $19.46 +21.9% $9,312.0M $6,789.0M -0.4%
FY 2022 $44,915.0M +14.5% $18,971.0M $6,950.0M -10.0% $17.63 -9.4% $9,154.0M $6,911.0M +1.8%
FY 2023 $42,857.0M -4.6% $17,100.0M $5,995.0M -13.7% $15.45 -12.4% $8,406.0M $6,927.0M +0.2%
FY 2024 $42,879.0M +0.1% $17,702.0M $6,335.0M +5.7% $16.53 +7.0% $8,667.0M $7,267.0M +4.9%
FY 2025 $44,556.0M +3.9% $18,238.0M $6,704.0M +5.8% $17.74 +7.3% $7,818.0M $6,293.0M -13.4%
$

Valuation

Market Price $588.00
Market Cap $221.37B
Enterprise Value $250.69B
P/E Ratio 33.15
P/B Ratio 4.09
FCF Yield 2.84%
Dividend Yield 0.29%
Shares Outstanding 371,621,500
%

Profitability & Margins

Gross Margin 40.93%
Operating Margin 17.38%
Net Margin 15.05%
Return on Equity (ROE) 12.55%
Return on Assets (ROA) 6.08%
Asset Turnover 0.40x
Revenue 3-Yr CAGR -0.27%
🛡️

Financial Health & Liquidity

Current Ratio 1.89
Cash Ratio 0.65
Debt / Equity 0.733
Debt / Assets 0.355
Cash & Equivalents $9.85B
Total Debt $39.17B
Book Value / Share $143.71
💧

Cash Flow Efficiency

Operating Cash Flow $7.82B
Capital Expenditures (CapEx) $1.52B
Free Cash Flow $6.29B
OCF / Revenue 17.55%
FCF / Revenue 14.12%
FCF 3-Yr CAGR -3.07%
🏷️

Per Share Metrics

EPS (Diluted) $17.74
EPS (Basic) $17.77
Dividends / Share $1.72
Book Value / Share $143.71
EPS YoY Growth 7.32%
🏛️

Balance Sheet (FY 2025)

Total Assets $110.34B
Total Liabilities $110.34B
Stockholders' Equity $53.41B
Current Assets $28.71B
Current Liabilities $15.19B